MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue102,155132,499166,858
Cost of Revenue71,71088,026109,927
Gross Profit30,44544,47356,931
Operating Expenses
Research Development6421,8694,251
Selling General and Administrative36,81250,36184,334
Non Recurring18090118,293
Others---
Total Operating Expenses---
Operating Income or Loss-7,189-8,658-49,947
Income from Continuing Operations
Total Other Income/Expenses Net-3,6425,499-1,806
Earnings Before Interest and Taxes-10,831-3,159-51,753
Interest Expense---
Income Before Tax-10,831-3,159-51,753
Income Tax Expense142318105
Minority Interest---
Net Income From Continuing Ops-10,973-3,477-51,858
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-10,973-3,477-51,858
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-10,973-3,477-51,858